| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |